Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 4,861 | 12,256 | 5,657 | 4,707 | 4,796 |
| Operating Income | -4,861 | -12,256 | -5,657 | -4,707 | -4,796 |
| Interest Expense | 0 | 0 | 0 | 1 | 4 |
| Other Income | 183 | 2,092 | 3,178 | 1,917 | 276 |
| Pre-tax Income | -4,678 | -10,164 | -2,479 | -2,791 | -4,524 |
| Net Income Continuous | -4,678 | -8,678 | -2,479 | -2,791 | -4,524 |
| Net Income | $-4,678 | $-8,678 | $-2,479 | $-2,791 | $-4,524 |
| EPS Basic Total Ops | -415.76 | -624.54 | -262.77 | -491.35 | -961.10 |
| EPS Basic Continuous Ops | -405.14 | -611.60 | -249.67 | -476.51 | -961.32 |
| EPS Diluted Total Ops | -415.76 | -624.54 | -262.77 | -491.35 | -961.10 |
| EPS Diluted Continuous Ops | -405.14 | -611.60 | -249.67 | -476.51 | -961.32 |
| EBITDA(a) | $-4,747 | $-4,712 | $-5,536 | $-4,587 | $-4,692 |